Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 9601-9650 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT04348123
Interventional Program Educates, Identifies + Overcomes Barriers to Complete Screening Mammography
NAActive, not recruiting
203 participants
Started: Mar 15, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT05350267
Changing Health and Lifestyle Behaviors of Offspring Following Maternal Bariatric Surgery
NAActive, not recruiting
50 participants
Started: Mar 14, 2022 · Completed: May 31, 2025
1 condition2 sponsors1 location
NCT05200988
Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC
PHASE2Active, not recruiting
50 participants
Started: Mar 14, 2022 · Completed: Sep 5, 2027
2 conditions2 sponsors3 locations
NCT03361852
Personalized Neoantigen Cancer Vaccine + Pembrolizumab After Rituximab for Follicular Lymphoma
PHASE1Active, not recruiting
20 participants
Started: Mar 14, 2022 · Completed: Dec 26, 2033
1 condition1 sponsor1 location
NCT05262400
A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors
PHASE1/PHASE2Active, not recruiting
192 participants
Started: Mar 14, 2022 · Completed: Aug 23, 2026
2 conditions1 sponsor51 locations
NCT05185583
Methylphenidate in Childhood Apraxia of Speech
PHASE2Active, not recruiting
18 participants
Started: Mar 14, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT05035810
A Pragmatic Trial to Determine the Benefit of Behaviorally Enhanced Exercise Incentives and Corticosteroid Injections in Osteoarthritis of the Knee Marching On for Veterans With Osteoarthritis of the Knee
PHASE3Active, not recruiting
221 participants
Started: Mar 14, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor4 locations
NCT05379348
Davos Alzheimer's Collaborative Study: Sequential Administration of Digital Testing To Screen For Cognitive Impairment Followed By Blood Based Biomarkers To Assist With Timely Detection And Accurate Diagnosis Of Alzheimer's Disease
N/AActive, not recruiting
1,423 participants
Started: Mar 14, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06292026
Efficacy of ProgenaMatrix™ in the Management of DFUs
NAActive, not recruiting
100 participants
Started: Mar 14, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT05257772
Electromechanically Optimised Right Ventricular Pacing In Hypertrophic Cardiomyopathy (EMORI-HCM)
NAActive, not recruiting
60 participants
Started: Mar 14, 2022 · Completed: May 16, 2025
2 conditions2 sponsors1 location
NCT05345561
Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia
N/AActive, not recruiting
30,000 participants
Started: Mar 14, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor28 locations
NCT04928599
Financial Distress During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States
N/AActive, not recruiting
100 participants
Started: Mar 14, 2022 · Completed: Mar 31, 2028
1 condition1 sponsor40 locations
NCT05295017
LEVANTIS-0093A: GAGomes for Multi-Cancer Early Detection in High-Risk Adults (LEV93A)
N/AActive, not recruiting
1,235 participants
Started: Mar 14, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05343793
Stagewise Implementation-To-Target- Medications for Addiction Treatment (SITT-MAT)
NAActive, not recruiting
47 participants
Started: Mar 14, 2022 · Completed: Jun 30, 2026
1 condition4 sponsors1 location
NCT06191497
The Effect of Smoking and Chlorhexidine on Periodontal Tissues After Non- Surgical Periodontal Therapy in Patients With Periodontitis
NAActive, not recruiting
60 participants
Started: Mar 14, 2022 · Completed: May 1, 2024
3 conditions1 sponsor1 location
NCT06889207
Physical Exercise Prehabilitation Program in MEtabolic SuRgery
NAActive, not recruiting
58 participants
Started: Mar 14, 2022 · Completed: May 31, 2026
6 conditions1 sponsor1 location
NCT05257395
A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast Cancer
PHASE3Active, not recruiting
397 participants
Started: Mar 14, 2022 · Completed: Sep 5, 2030
1 condition1 sponsor1 location
NCT05111626
Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer.
PHASE3Active, not recruiting
515 participants
Started: Mar 14, 2022 · Completed: Jan 29, 2027
2 conditions1 sponsor348 locations
NCT05350592
Low-Dose Dobutamine and Single-Dose Tocilizumab in Acute Myocardial Infarction With High Risk of Cardiogenic Shock
PHASE2Active, not recruiting
100 participants
Started: Mar 13, 2022 · Completed: Sep 30, 2025
2 conditions4 sponsors1 location
NCT05289167
Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)
PHASE1/PHASE2Active, not recruiting
74 participants
Started: Mar 13, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05169567
Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer
PHASE3Active, not recruiting
368 participants
Started: Mar 11, 2022 · Completed: Feb 28, 2026
2 conditions1 sponsor138 locations
NCT05228197
Imperial Prostate 6 - Cancer Histology Artificial Intelligence Reliability Study.
N/AActive, not recruiting
750 participants
Started: Mar 11, 2022 · Completed: Apr 30, 2025
1 condition2 sponsors6 locations
NCT06069687
Administration of MELPIDA to Determine the Safety and Efficacy for Patients With Spastic Paraplegia Type 50
PHASE1Active, not recruiting
1 participants
Started: Mar 11, 2022 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT05267587
Preop fSRS for Resectable Brain Metastases
PHASE2Active, not recruiting
49 participants
Started: Mar 11, 2022 · Completed: Aug 21, 2026
2 conditions1 sponsor1 location
NCT05284266
The National Lipedema Study
NAActive, not recruiting
220 participants
Started: Mar 11, 2022 · Completed: Dec 31, 2027
1 condition7 sponsors1 location
NCT05329090
Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis
PHASE3Active, not recruiting
75 participants
Started: Mar 11, 2022 · Completed: Jan 16, 2026
1 condition2 sponsors14 locations
NCT05289193
CD8+ T Cell Imaging During Pre-surgery Immunotherapy in People With Melanoma
PHASE2Active, not recruiting
28 participants
Started: Mar 11, 2022 · Completed: Mar 11, 2026
2 conditions1 sponsor4 locations
NCT04729959
Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma
PHASE2Active, not recruiting
59 participants
Started: Mar 11, 2022 · Completed: Sep 4, 2026
2 conditions2 sponsors110 locations
NCT06980818
Oral Microbiota Dysbiosis in IBD
N/AActive, not recruiting
130 participants
Started: Mar 11, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05206773
A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry Disease
PHASE3Active, not recruiting
122 participants
Started: Mar 11, 2022 · Completed: Jan 4, 2027
1 condition1 sponsor58 locations
NCT05147181
A Study With Lanadelumab in Persons With Hereditary Angioedema (HAE) in Poland
N/AActive, not recruiting
48 participants
Started: Mar 11, 2022 · Completed: Mar 28, 2026
1 condition1 sponsor14 locations
NCT05143164
Hydrocolloid Dressing for Catheter Exit Site Care in Peritoneal Dialysis Patients
NAActive, not recruiting
60 participants
Started: Mar 11, 2022 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT05330078
Examining the Therapeutic Potential of Botulinum Toxin Type A in the Treatment of Keloids
EARLY_PHASE1Active, not recruiting
10 participants
Started: Mar 11, 2022 · Completed: Jan 31, 2032
1 condition1 sponsor1 location
NCT05213338
Wear-documentation and Orthodontic Appliance Compliance
NAActive, not recruiting
52 participants
Started: Mar 10, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05201248
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab As Monotherapy or Combined With Standard of Care Therapies in Adult Participants in China With B-Cell Non-Hodgkin Lymphoma
PHASE1/PHASE2Active, not recruiting
49 participants
Started: Mar 10, 2022 · Completed: Apr 30, 2025
1 condition2 sponsors18 locations
NCT04577859
Esophageal Protection Study: A Multicenter Study
NAActive, not recruiting
152 participants
Started: Mar 10, 2022 · Completed: May 31, 2026
3 conditions6 sponsors6 locations
NCT05205499
A Clinical Trial to Evaluate the Safety and Efficacy of IBS in Patients With Coronary Artery Disease
NAActive, not recruiting
1,059 participants
Started: Mar 10, 2022 · Completed: Aug 31, 2028
1 condition1 sponsor1 location
NCT04265950
Establishing Optimal Number of Doses for HPV Vaccination in Children and Adolescents Living With HIV, OPTIMO Trial
PHASE4Active, not recruiting
97 participants
Started: Mar 10, 2022 · Completed: Jul 31, 2026
1 condition5 sponsors3 locations
NCT04836429
Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease
PHASE1Active, not recruiting
5 participants
Started: Mar 10, 2022 · Completed: Jan 3, 2026
2 conditions1 sponsor1 location
NCT04298905
Leveraging mHealth to Enable and Adapt CHW Strategies to Improve TB/HIV Patient Outcomes in SA
NAActive, not recruiting
62 participants
Started: Mar 10, 2022 · Completed: Dec 31, 2025
4 conditions2 sponsors1 location
NCT06743438
Long-term Safety and Efficacy of Tenofovir Amibufenamide in Patients With CHB
PHASE4Active, not recruiting
640 participants
Started: Mar 10, 2022 · Completed: Sep 30, 2029
1 condition1 sponsor1 location
NCT05096182
Long-term Follow-up of Patients With Chronic Kidney Disease Who Had Administered Cellgram-CKD in PMC-P-12 Study
N/AActive, not recruiting
10 participants
Started: Mar 10, 2022 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT04904536
Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy
PHASE3Active, not recruiting
190 participants
Started: Mar 10, 2022 · Completed: Jul 30, 2025
1 condition7 sponsors1 location
NCT05189470
Inforatio Technique to Promote Wound Healing of Diabetic Foot Ulcers
NAActive, not recruiting
100 participants
Started: Mar 10, 2022 · Completed: Feb 28, 2025
6 conditions2 sponsors4 locations
NCT04975841
Inclusion Body Myositis Treatment With Celution Processed Adipose Derived Regenerative Cells
NAActive, not recruiting
9 participants
Started: Mar 10, 2022 · Completed: Sep 29, 2025
1 condition1 sponsor1 location
NCT05206084
A Clinical Investigation to Evaluate the Safety and Efficacy of IBS in Patients With Coronary Artery Disease
NAActive, not recruiting
518 participants
Started: Mar 10, 2022 · Completed: Jan 31, 2028
1 condition1 sponsor1 location
NCT05250505
Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus
NAActive, not recruiting
30 participants
Started: Mar 10, 2022 · Completed: Apr 30, 2027
2 conditions4 sponsors1 location
NCT05192031
Implementation of Smoking Cessation Support During Lung Cancer Workup
NAActive, not recruiting
295 participants
Started: Mar 9, 2022 · Completed: Dec 31, 2025
1 condition9 sponsors1 location
NCT05215067
A Phase II Trial of AK104 in Advanced Non-Small Cell Lung Cancer
PHASE2Active, not recruiting
44 participants
Started: Mar 9, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05075824
A Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab as Adjunct Treatment in Prevention of Vaso-Occlusive Episodes (VOE) in Sickle Cell Disease (SCD)
PHASE2Active, not recruiting
90 participants
Started: Mar 9, 2022 · Completed: Apr 8, 2026
1 condition1 sponsor28 locations